Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Astellas Pharma (4503.T) has a market cap of $16.49 billion USD. According to our data, Astellas Pharma is ranked No.1082 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $16.49 B |
-14.13%
|
| Dec 30, 2024 | $19.21 B |
-5.02%
|
| Dec 29, 2023 | $20.22 B |
-13.23%
|
| Dec 30, 2022 | $23.30 B |
10.42%
|
| Dec 30, 2021 | $21.11 B |
20.38%
|
| Dec 30, 2020 | $17.53 B |
-12.64%
|
| Dec 30, 2019 | $20.07 B |
36.69%
|
| Dec 31, 2018 | $14.68 B |
-0.39%
|
| Dec 29, 2017 | $14.74 B |
-9.35%
|
| Dec 30, 2016 | $16.26 B |
-4.27%
|
| Dec 30, 2015 | $16.99 B |
4.53%
|
| Dec 30, 2014 | $16.25 B |
38.17%
|
| Dec 30, 2013 | $11.76 B |
64.98%
|
| Dec 28, 2012 | $7.13 B |
28.22%
|
| Dec 30, 2011 | $5.56 B |
5.48%
|
| Dec 30, 2010 | $5.27 B |
-7.03%
|
| Dec 30, 2009 | $5.67 B |
-1.33%
|
| Dec 30, 2008 | $5.75 B |
-23.29%
|
| Dec 28, 2007 | $7.49 B |
-8.42%
|
| Dec 29, 2006 | $8.18 B |
19.66%
|
| Dec 30, 2005 | $6.84 B |
16.63%
|
| Dec 31, 2004 | $5.86 B |
20.86%
|
| Dec 31, 2003 | $4.85 B |
-2.60%
|
| Dec 31, 2002 | $4.98 B |
-0.32%
|
| Dec 31, 2001 | $4.99 B |
-29.49%
|
| Dec 29, 2000 | $7.08 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
Japan
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
| Market Cap | = | 4503.T Stock Price | * | 4503.T Shares Outstanding |
| = | $9.21 | * | 1.79 B | |
| = | $16.49 B |